Ring Augmentation and Pouch Resizing for the Treatment of Dumping Syndrome After Roux-en-Y Gastric Bypass: A Prospective Single-Center Trial
Authors:
- Jodok Matthias FinkJFJodok Matthias Fink
- Mareike LuehnMLMareike Luehn
- Maximilian Meyer-SteenbuckMMMaximilian Meyer-Steenbuck
- Gabriel SeifertGSGabriel Seifert
- Sephan HerrmannSHSephan Herrmann
- Stefan Fichtner-FeiglSFStefan Fichtner-Feigl
- Jochen SeufertJSJochen Seufert
- Goran MarjanovicGMGoran Marjanovic
- Katharina LaubnerKLKatharina Laubner
Open Access
- 22 September 2025
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (10) , 4062-4070
Abstract
Background: Early dumping syndrome (DS) and postbariatric surgery hypoglycemia (PBH) are common side effects after Roux-en-Y gastric bypass (RYGB) and may substantially impact patients’ quality of life. Established management options provide limited response in many patients. This trial tested the effect of pouch resizing and silicone ring implantation (trial intervention) in patients with dumping symptoms after RYGB. Methods: The trial intervention was assessed in a prospective single-arm trial including 16 patients. The primary endpoint was the change in Sigstad score 12 months after surgery. Secondary endpoints included Arts dumping score, insulin secretion, and glucose uptake assessed by a mixed meal tolerance test (MMTT), weight loss, quality of life, and safety evaluated by gastroscopy and contrast swallow. Results: The trial intervention led to a significant improvement in Sigstad (preOP: 20.4 (95% CI 17.8–23.1); 12 months: 10.4 (6.7–14.1); P = 0.0002) and Arts dumping score (preOP: 20.3 (16.7–23.9); 12 months: 10 (6.5–13.5); P = 0.0001). Glucose uptake and insulin secretion during MMTT remained largely unchanged (AUC glucose: 21,526 (19,654–23,398) mg/dl*min vs. 12 months 22,294 (20,511–24077) mg/dl*min), P = 0.21; AUC insulin: (preOP 62897 (33,531–92,263) pmol/l*min vs. 12 months 68,974 (40,691–97257) pmol/l*min, P = 0.19). Following the trial intervention, mean weight loss was 5.1% (1.4–8.9%). No ring migration or misplacement occurred during follow-up. Conclusions: Pouch resizing and silicone ring implantation led to a clinically relevant improvement in symptoms associated with DS and PBH. This was not related to an apparent impact on glycemic regulation. GraphicalKeywords
Funding Information
- University of Freiburg, internal funding
- German Diabetes Association
- Universitätsklinikum Freiburg
This publication has 20 references indexed in Scilit:
- Technical Considerations of Ring-Augmented Laparoscopic Sleeve Gastrectomy: A Step-by-step Guide for Ring Placement by Various ExpertsObesity Surgery, 2025
- Postbariatric surgery hypoglycemia: Nutritional, pharmacological and surgical perspectivesDiabetes/Metabolism Research and Reviews, 2023
- Long-term Outcomes of Transoral Outlet Reduction (TORe) for Dumping Syndrome and Weight Regain After Roux-en-Y Gastric BypassObesity Surgery, 2023
- The efficacy of GLP‐1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic reviewObesity, 2022
- Surgical Treatment for Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass: a Literature ReviewObesity Surgery, 2021
- Banding the Pouch with a Non-adjustable Ring as Revisional Procedure in Patients with Insufficient Results After Roux-en-Y Gastric Bypass: Short-term Outcomes of a Multicenter Cohort StudyObesity Surgery, 2020
- Gastric Emptying and Food Tolerance Following Banded and Non-banded Roux-en-Y Gastric BypassObesity Surgery, 2018
- Roux en Y gastric bypass hypoglycemia resolves with gastric feeding or reversal: Confirming a non-pancreatic etiologyMolecular Metabolism, 2018
- Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypassSurgery for Obesity and Related Diseases, 2016
- Standardized Outcomes Reporting in Metabolic and Bariatric SurgeryObesity Surgery, 2015